About 100 reports

  • Growth in Neurology Devices Market driven by Greater Acceptance of Neurostimulation Devices
  • Canada Neurology Devices Market: By Type, By Value, 2017-2022 (USD Million)

New devices to treat conditions like obesity, depression and gastrointestinal disorder are expected to enter market in next five years.

  • Neurology
  • World
  • Boston Scientific Corporation
  • Integra LifeSciences Holdings Corporation
  • Jude Medical, Inc.

Neuromodulation: Includes implantable neurostimulation and targeted drug delivery systems for the treatment of common movement disorders, chronic pain, spasticity, and urologic and gastrointestinal disorders.

  • Neurology
  • C.R. Bard, Inc.
  • Cook Medical, Inc.
  • Endologix, Inc.
  • Medtronic, Inc.

NOTE: OTHER THERAPEUTIC APPLICATIONS INCLUDE BREAST CANCER, CERVICAL CANCER, GASTROINTESTINAL TUMORS, AND RENAL TUMORS. ##% ##% Primary' s Viewpoint: _________________________________________________________________ Market Share (%), 2015 CAGR% (2016-2021) Therapeutic Other Therapeuti

  • Neurology
  • Europe
  • North America
  • World
  • Market Size

The company focuses on design and development of devices using neuroblocking technology to treat obesity and other gastrointestinal disorders.

  • Neurology
  • Urology Device
  • World
  • Market Size
  • Boston Scientific Corporation
  • Neurology
  • Endologix, Inc.
  • Medtronic, Inc.
  • Nellix, Inc.
  • TriVascular, Inc.

Neuromodulation includes implantable neurostimulation and targeted drug delivery systems for the management of chronic pain, common movement disorders, spasticity, and urologic and gastrointestinal disorders.

  • Neurology
  • United States
  • Medtronic, Inc.
  • Penumbra
  • Stryker Corporation

Gastrointestinal, Pain Management, and Others.............. ## Multiple Sclerosis.............. ## Table ##: Multiple Sclerosis Disease Occurrence by Type Worldwide (2014) - Percentage Breakdown by Volume for Begin MS, Primary Progressive MS, Relapsing-Remiting MS, and Secondary Progressive MS.

  • Neurology
  • Therapy
  • World
  • Demand
  • Market Shares
  • Number of Cerebral Palsy patients with gastrointestinal malformations, total (000s)
  • Number of Cerebral Palsy patients with genitourinary malformations, total (000s)
  • Health Services
  • Neurological Disorder
  • Neurology
  • Europe
  • Japan

According to the AHA, antiplatelet therapy is not recommended for patients with a history of asthma, bleeding disorders, gastrointestinal disease, high blood pressure, liver and kidney disease, and peptic ulcers; patients with a history of the aforementioned conditions may require special d

  • Neurology
  • United States
  • Forecast
  • GE Healthcare Limited
  • Stryker Corporation
  • Trial Results

gastrointestinal illness or other gastrointestinal disorder that may, in the investigator' s opinion, affect the absorption of study drug In the investigator' s opinion, have clinically significant abnormalities on clinical examination or laboratory testing In the investiga

  • Clinical Trial
  • Drug Discovery And Development
  • Neurology
  • Therapy
  • Baxter International Inc.

cardiac, renal, pulmonary, hepatic, or gastrointestinal), current malignancy, or anamnestic HIV infection Clinically relevant pathological findings in laboratory parameters, indicating active disease of vital organs Anticoagulation therapy which requires an INR value of > ##. ## INR valu

  • Neurology
  • World
  • Allergan plc
  • GlaxoSmithKline plc
  • GW Pharmaceuticals plc

Other adverse events experienced by the subjects were eye disorders, gastrointestinal disorders, skin and subcutaneous tissue disorders, infections and infestations and general disorders like pyrexia, pain and fatigue.

  • Neurology
  • Eisai Co., Ltd.
  • Otsuka Pharmaceutical Co., Ltd.
  • UCB Japan Co., Ltd.
  • UCB S.A.

The market structure of OTC drugs sales in China is relatively stagnant with nearly a ##% market share contributed by the cold, cough and allergy treatments; vitamins, minerals and tonics, gastrointestinal, anti-inflammatory and gynecological treatments contribute to nearly ##%; Table ##. ##. ##

  • Neurology
  • Asia
  • China
  • Market Size
  • Novo Nordisk Group

Othe adverse events: ##. ## ##. ## ##. ## ##. ## ##. ## ##. ## ##. ## ##. ## ##. ## ##. ## ##. ## ##. ## ##. ## ##. ## ##. ## ##. ## ##. ## ##. ## ##. ## ##. ## ##. ## ##. ## ##. ## ##. ## TOTAL, OTHER (NOT INCLUDING SERIOUS) ADVERSE EVENTS GASTROINTESTINAL DISORDERS Nausea NERVOUS SYSTEM DISORDERS Dizziness Headache Somnolence P

  • Chronic Pain
  • Neurology
  • World
  • Market Size
  • Pfizer Inc.

PRIOR TO THAT, SHE WORKED AS A PRODUCT DEVELOPMENT ENGINEER AT AN NIH-FUNDED SBIR FIRM WORKING ON GASTROINTESTINAL BIOPSY AND ORTHOPEDIC DEVICES.

  • Neurology
  • Altura Medical, Inc.
  • Cordis Corporation
  • Endologix, Inc.
  • Getinge Group

PRIOR TO THAT, SHE WORKED AS A PRODUCT DEVELOPMENT ENGINEER AT AN NIH-FUNDED SBIR FIRM WORKING ON GASTROINTESTINAL BIOPSY AND ORTHOPEDIC DEVICES.

  • Neurology
  • Altura Medical, Inc.
  • Cordis Corporation
  • Endologix, Inc.
  • Medtronic, Inc.

PRIOR TO THAT, SHE WORKED AS A PRODUCT DEVELOPMENT ENGINEER AT AN NIH-FUNDED SBIR FIRM WORKING ON GASTROINTESTINAL BIOPSY AND ORTHOPEDIC DEVICES.

  • Neurology
  • Altura Medical, Inc.
  • Cordis Corporation
  • Endologix, Inc.
  • Medtronic, Inc.

PRIOR TO THAT, SHE WORKED AS A PRODUCT DEVELOPMENT ENGINEER AT AN NIH-FUNDED SBIR FIRM WORKING ON GASTROINTESTINAL BIOPSY AND ORTHOPEDIC DEVICES.

  • Neurology
  • Altura Medical, Inc.
  • Cordis Corporation
  • Endologix, Inc.
  • Medtronic, Inc.

The gastrointestinal therapeutics market recorded ## partnership deals and six licensing deals worth USD##. ## billion in Q## 2016.

  • Endocrine Disease
  • Neurology
  • World
  • Deals & Alliance
  • AstraZeneca PLC

a company specializing in the development of non-systemic, recombinant therapies for gastrointestinal diseases, is providing an update on the ongoing open-label Phase IIa trial of lead candidate MS## for the treatment of exocrine pancreatic insufficiency (EPI) associated with chronic p

  • Digestive System Disorder
  • Neurology
  • Pathology
  • World
  • Product Initiative
  • IPSEN SA, DEALS BY THERAPY AREA, 2011 TO YTD 2017

IT FOCUSES ON PRODUCTS FOR THE IMPROVING GASTROINTESTINAL HEALTH AND THE IMMUNE SYSTEM.

  • Neurology
  • Pharmaceutical
  • United States
  • Demand
  • Ipsen S.A.
  • LUPIN LTD, DEALS BY THERAPY AREA, 2011 TO YTD 2017
  • Company Overview

It is indicated for the treatment of gastrointestinal tract spasms, dyskinesias of the biliary tract and genitourinary tract spasms in adults and children over ## years.

  • Anti-Infective
  • Neurology
  • Demand
  • M&A
  • Lupin Ltd
  • Clinical Trial profile. 144 Trial Title
  • Clinical Trial profile. 53 Trial Title

Gastrointestinal Adverse Events Associated with a Colonoscopy Purgative The Effects of Nexium on the Side Effects Associated with a Colonoscopy Prep GDCT## NCT##, ##C. ## Central Nervous System Abdominal Pain, Emesis (Vomiting), Nausea Completed Phase IV Interventional esomepraz

  • Digestive System Disorder
  • Hospital
  • Neurology
  • World
  • Product Initiative
  • Clinical Trial profile. 137 Trial Title
  • Clinical Trial profile. 122 Trial Title

Gastrointestinal Spasm: A Post Marketing Observational Program in the Russian Federation Effectiveness of Duspatalin in Patients with Post-cholecystectomy Gastrointestinal Spasm (ODYSSEY) GDCT## NCT##, MEBE## Central Nervous System Abdominal Pain, Unspecified

  • Digestive System Disorder
  • Gastrointestinal Drug
  • Neurology
  • World
  • Product Initiative
  • DR. REDDY'S LABS AND INTEGRA LIFESCIENCES HOLDINGS ENTER INTO DISTRIBUTION AGREEMENT

Equipment.

  • Navigation Systems
  • Neurology
  • Asia
  • India
  • Integra LifeSciences Holdings Corporation
  • NUMBER OF PRODUCTS UNDER DEVELOPMENT BY THERAPY AREA, H2 2016
  • NUMBER OF PRODUCTS UNDER DEVELOPMENT BY THERAPY AREAS, H2 2017

It offers its products for the therapeutic conditions of bone and joint diseases, cardiovascular diseases, central nervous system diseases, circulatory system, dermatological, gastrointestinal, and respiratory remedies, among others.

  • Neurology
  • Pain Relief
  • Pharmaceutical
  • Therapy
  • Flex Pharma, Inc.

United Kingdom Neurology Devices Market Outlook to 2023 - CSF Management, Interventional Neurology, Neurostimulation Devices, Neurosurgical Products, Radiosurgery and Neurological Diagnostic Equipment.

  • Neurology
  • Europe
  • United Kingdom
  • Demand
  • Forecast
  • Optiscan Imaging Raises USD1.4 Million in Private Placement of Shares

Australia Neurology Devices Market Outlook to 2023 - CSF Management, Interventional Neurology, Neurostimulation Devices, Neurosurgical Products, Radiosurgery and Neurological Diagnostic Equipment.

  • Medical Device
  • Neurology
  • Australia
  • Oceania
  • Medtronic, Inc.

Tension -Type Headache Global Clinical Trials Review, H##, 2016 Reference Code: GDHC##CTIDB Publication Date: NOV 2016 LIST OF TABLES LIST OF FIGURES Tension -Type Headache Global Clinical Trials Review, H##, 2016 outlines clinical trials in Tension -Type Headache.

  • Neurology
  • OTC
  • Pain Relief
  • Pharmaceutical
  • GlaxoSmithKline plc
  • Company type
  • Company type

LNK offers national brand equivalent formulas in the pain relief, cough and cold, and gastrointestinal categories.

  • Neurology
  • Pharmaceutical
  • United States
  • Company
  • Sandoz Inc.